
Inventurus Knowledge (IKS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
7.2B
Gross Profit
7.2B
100.00%
Operating Income
2.0B
27.74%
Net Income
1.5B
20.42%
Balance Sheet Metrics
Total Assets
30.5B
Total Liabilities
12.6B
Shareholders Equity
17.9B
Debt to Equity
0.71
Cash Flow Metrics
Revenue & Profitability Trend
Inventurus Knowledge Income Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue | 26.6B | 18.2B | 10.3B | 7.6B |
Cost of Goods Sold | 7.5M | 7.1M | 0 | 0 |
Gross Profit | 26.6B | 18.2B | 10.3B | 7.6B |
Gross Margin % | 100.0% | 100.0% | 100.0% | 100.0% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | - | 1.4B | 456.6M | 400.8M |
Other Operating Expenses | 4.0B | 3.4B | 794.1M | 404.2M |
Total Operating Expenses | 4.0B | 4.7B | 1.3B | 805.0M |
Operating Income | 6.6B | 4.6B | 3.7B | 2.8B |
Operating Margin % | 24.7% | 25.4% | 35.9% | 36.2% |
Non-Operating Items | ||||
Interest Income | - | 300.0M | 284.0M | 202.1M |
Interest Expense | 897.6M | 600.9M | 53.6M | 64.5M |
Other Non-Operating Income | - | - | - | - |
Pre-tax Income | 6.1B | 4.4B | 3.6B | 2.7B |
Income Tax | 1.2B | 711.8M | 541.2M | 355.5M |
Effective Tax Rate % | 19.8% | 16.1% | 15.1% | 13.2% |
Net Income | 4.9B | 3.7B | 3.1B | 2.3B |
Net Margin % | 18.2% | 20.4% | 29.6% | 30.5% |
Key Metrics | ||||
EBITDA | 8.1B | 5.6B | 4.2B | 3.2B |
EPS (Basic) | ₹29.20 | ₹21.59 | ₹17.79 | ₹13.58 |
EPS (Diluted) | ₹28.62 | ₹21.59 | ₹17.79 | ₹13.58 |
Basic Shares Outstanding | 166458562 | 171573159 | 171573159 | 171573159 |
Diluted Shares Outstanding | 166458562 | 171573159 | 171573159 | 171573159 |
Income Statement Trend
Inventurus Knowledge Balance Sheet From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Assets | ||||
Current Assets | ||||
Cash & Equivalents | 1.8B | 1.4B | 1.2B | 1.5B |
Short-term Investments | 382.5M | 3.4B | 4.0B | 2.0B |
Accounts Receivable | 5.3B | 3.5B | 1.5B | 972.8M |
Inventory | 0 | 7.5M | 0 | 0 |
Other Current Assets | 331.4M | 17.4M | - | 47.8M |
Total Current Assets | 7.8B | 9.0B | 7.0B | 4.6B |
Non-Current Assets | ||||
Property, Plant & Equipment | 1.2B | 613.6M | 378.0M | 336.4M |
Goodwill | 28.7B | 28.5B | 13.4M | 5.3M |
Intangible Assets | 4.8B | 5.1B | 13.4M | 5.3M |
Long-term Investments | - | 0 | 0 | 0 |
Other Non-Current Assets | 320.4M | - | - | - |
Total Non-Current Assets | 22.7B | 21.3B | 2.9B | 3.3B |
Total Assets | 30.5B | 30.3B | 9.9B | 7.9B |
Liabilities | ||||
Current Liabilities | ||||
Accounts Payable | 759.6M | 677.4M | 216.9M | 96.5M |
Short-term Debt | 2.7B | 4.0B | 130.1M | 139.7M |
Current Portion of Long-term Debt | - | - | - | - |
Other Current Liabilities | 1.0B | - | - | - |
Total Current Liabilities | 5.2B | 7.9B | 1.1B | 828.2M |
Non-Current Liabilities | ||||
Long-term Debt | 5.9B | 9.1B | 393.4M | 512.2M |
Deferred Tax Liabilities | 1.3B | 1.5B | 0 | 0 |
Other Non-Current Liabilities | - | - | - | - |
Total Non-Current Liabilities | 7.4B | 10.8B | 447.3M | 576.3M |
Total Liabilities | 12.6B | 18.7B | 1.6B | 1.4B |
Equity | ||||
Common Stock | 170.2M | 169.2M | 168.4M | 168.1M |
Retained Earnings | - | 9.3B | 7.3B | 5.6B |
Treasury Stock | - | - | - | - |
Other Equity | - | - | - | - |
Total Shareholders Equity | 17.9B | 11.6B | 8.3B | 6.5B |
Key Metrics | ||||
Total Debt | 8.6B | 13.1B | 523.5M | 651.9M |
Working Capital | 2.6B | 1.1B | 5.8B | 3.8B |
Balance Sheet Composition
Inventurus Knowledge Cash Flow Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | 6.1B | 4.4B | 3.6B | 2.7B |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | 277.3M | 85.6M | 25.1M | 9.3M |
Working Capital Changes | -3.9B | -2.0B | -435.5M | -224.2M |
Operating Cash Flow | 3.0B | 2.7B | 3.3B | 2.5B |
Investing Activities | ||||
Capital Expenditures | -241.8M | -263.2M | -75.0M | -107.4M |
Acquisitions | -644.5M | -14.1B | 0 | 0 |
Investment Purchases | -1.1M | -1.4B | -3.6B | -3.0B |
Investment Sales | 3.2B | 4.1B | 1.9B | 2.1B |
Investing Cash Flow | 2.4B | -11.7B | -1.8B | -936.5M |
Financing Activities | ||||
Share Repurchases | -229.6M | -1.4M | -1.1B | -1.3M |
Dividends Paid | - | -1.7B | - | -442.6M |
Debt Issuance | 0 | 10.3B | 0 | 0 |
Debt Repayment | -3.3B | -332.8M | 0 | 0 |
Financing Cash Flow | -2.8B | 8.4B | -1.2B | -400.8M |
Free Cash Flow | 2.8B | 1.8B | 2.8B | 2.2B |
Net Change in Cash | 2.6B | -644.8M | 234.1M | 1.2B |
Cash Flow Trend
Inventurus Knowledge Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
48.62
Forward P/E
31.60
Price to Book
14.63
Price to Sales
9.51
Profitability Ratios
Profit Margin
19.61%
Operating Margin
28.35%
Return on Equity
27.16%
Return on Assets
15.93%
Financial Health
Current Ratio
1.50
Debt to Equity
47.81
Per Share Data
EPS (TTM)
₹32.35
Book Value per Share
₹107.53
Revenue per Share
₹165.80
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
iks | 260.5B | 48.62 | 14.63 | 27.16% | 19.61% | 47.81 |
Sagility India | 209.4B | 32.13 | 2.56 | 6.47% | 11.31% | 16.82 |
Indegene | 138.0B | 31.74 | 5.26 | 15.55% | 14.89% | 3.88 |
JSW Steel | 602.5M | 1,012.50 | 1.23 | 0.27% | -9.49% | 41.10 |
Sun Pharmaceutical | 3.9T | 37.28 | 5.37 | 15.08% | 19.29% | 3.26 |
Divi's Laboratories | 1.6T | 69.80 | 10.74 | 14.64% | 23.89% | 0.03 |
Financial data is updated regularly. All figures are in the company's reporting currency.